|
10 Mar 2008 |
Oxford Biomedica completes patient recruitment for Phase III trist study of Trovax (R) in renal cancer
|
|
10 Mar 2008 |
Genitope Corporation to Suspend Development of MyVax(R) Personalized Immunotherapy
|
|
07 Mar 2008 |
THE LANCET publishes phase IIa study results with Cytos Biotechnology’s hypertension vaccine CYT006-AngQb
|
|
27 Feb 2008 |
Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
|
|
27 Feb 2008 |
Intercell completes Phase I clinical trial for improved seasonal Flu vaccine formulated with IC31(R)
|
|
25 Feb 2008 |
Acambis initiates pre-clinical testing with herpes vaccine from Harvard Medical School
|
|
25 Feb 2008 |
GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
|
|
20 Feb 2008 |
Oxford Biomedica announces data safety monitoring board recommendation to continue TroVax (R) Phase III trist study
|
|
20 Feb 2008 |
GlaxoSmithKline receives favourable recommendation by FDA Advisory Committee for Rotarix(R)
|
|
15 Feb 2008 |
Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
|
|
14 Feb 2008 |
Vaccine formulated with Intercell's adjuvant IC31(R) part of a broader collaboration to fight TB
|
|
12 Feb 2008 |
Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
|
|
07 Feb 2008 |
Intercell's therapeutic Hepatitis C vaccine meets primary endpoints in Phase II
|
|
07 Feb 2008 |
GeoVax Labs, Inc.'s Promising HIV/AIDS Vaccine Trial Data Presented at Retrovirus Conference
|
|
22 Jan 2008 |
Medicago’s Pandemic Flu Vaccine Provides 100% Protection in Mice at Low Doses
|
|
17 Jan 2008 |
ICLL receives manufacturer's licence for future commercial manufacturing of its JE vaccine
|
|
16 Jan 2008 |
Intercell and PATH Malaria Vaccine Initiative Announce New Collaboration for Vaccine against Malaria
|
|
15 Jan 2008 |
Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
|
|
14 Jan 2008 |
Nventa completes evaluation of second cohort in HSPE7 Phase 1 cervical dysplasia trial
|
|
09 Jan 2008 |
New data show Menveo(TM) to be the first quadrivalent meningococcal vaccine to provide immunogenicity in infants
|
|
07 Jan 2008 |
Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
|
|
03 Jan 2008 |
Acambis reports positive data from trials of universal influenza A vaccine
|
|
31 Dec 2007 |
IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
|
|
27 Dec 2007 |
Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
|
|
24 Dec 2007 |
Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
|
